Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Global Glp 1 Receptor Agonists Obesity Drugs Market Market Size in USD Billion GLP-1 Receptor Agonists Obesity Drugs Market Size The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032 , at a CAGR of 16.21% during the forecast period The market growth is primarily driven by the increasing need for secure, transparent, and tamper-proof systems to manage sensitive healthcare data, billing processes, and patient records across diverse stakeholders In addition, the rising adoption of blockchain technology by healthcare providers, insurers, and pharmaceutical companies to streamline operations, enhance data integrity, and mitigate fraud is propelling market expansion
Bilirubin exerts renoprotective effects in angiotensin II-hypertension
Support Fat Loss While Preserving Lean Muscle Unlike traditional weight-loss methods, peptide therapy supports visceral fat and abdominal fat reduction while preserving lean muscle mass
Fat-dissolving treatments offer noticeable and gradual results, like a slimmer and more contoured appearance in the treated areas
K.ViswanathanM.KentR
The absorbance is recorded as AT, AC, AS, and AB, respectively
US$ 20.17
US$ 24.33
US$ 20.11
US$ 24.64
US$ 23.62
US$ 20.06
US$ 25.69
US$ 20.04
